Literature DB >> 20505149

Consequences of increased CD45RA and RC isoforms for TCR signaling and peripheral T cell deficiency resulting from heterogeneous nuclear ribonucleoprotein L-like mutation.

Zuopeng Wu1, Adele L Yates, Gerard F Hoyne, Christopher C Goodnow.   

Abstract

CD45 is the most abundant protein tyrosine phosphatase in the plasma membrane of T cells and serves a critical role in TCR signaling. Different CD45 isoforms are made by alternative mRNA splicing depending on the stage of T cell development and activation, yet their role remains unclear. Expression of CD45RA and RC isoforms is increased 20- to 200-fold on T cells from thunder mice with a loss-of-function mutation in the RNA-binding protein, heterogeneous nuclear ribonucleoprotein L-like (hnRNPLL), although total CD45 expression is unaltered. In this study, we test the hypothesis that this shift in CD45 isoform expression alters TCR signaling, thymic selection, and accumulation of peripheral T cells. There was no discernable effect of the change in CD45 isoform expression upon Lck phosphorylation or T cell positive and negative selection, whereas these indices were strongly affected by a decrease in the overall amount of CD45 in Ptprc mutant animals. The one exception to this conclusion was in thymocytes from Ptprc(loc/loc) animals with 4% of normal CD45 protein levels, where Lck505 phosphorylation was increased 25% in Hnrpll mutant cells, suggesting that high m.w. CD45 isoforms had lower Lck505 phosphatase activity in this context. In T cells with no CD45 protein, hnRNPLL mutation still diminished peripheral T cell accumulation, demonstrating that hnRNPLL regulates T cell longevity independently from its effects on CD45 splicing.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20505149     DOI: 10.4049/jimmunol.0903625

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Heterogeneous nuclear ribonucleoprotein L-like (hnRNPLL) and elongation factor, RNA polymerase II, 2 (ELL2) are regulators of mRNA processing in plasma cells.

Authors:  Micah J Benson; Tarmo Aijö; Xing Chang; John Gagnon; Utz J Pape; Vivek Anantharaman; L Aravind; Juha-Pekka Pursiheimo; Shalini Oberdoerffer; X Shirley Liu; Riitta Lahesmaa; Harri Lähdesmäki; Anjana Rao
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-18       Impact factor: 11.205

2.  Genetic variants regulating immune cell levels in health and disease.

Authors:  Valeria Orrù; Maristella Steri; Gabriella Sole; Carlo Sidore; Francesca Virdis; Mariano Dei; Sandra Lai; Magdalena Zoledziewska; Fabio Busonero; Antonella Mulas; Matteo Floris; Wieslawa I Mentzen; Silvana A M Urru; Stefania Olla; Michele Marongiu; Maria G Piras; Monia Lobina; Andrea Maschio; Maristella Pitzalis; Maria F Urru; Marco Marcelli; Roberto Cusano; Francesca Deidda; Valentina Serra; Manuela Oppo; Rosella Pilu; Frederic Reinier; Riccardo Berutti; Luca Pireddu; Ilenia Zara; Eleonora Porcu; Alan Kwong; Christine Brennan; Brendan Tarrier; Robert Lyons; Hyun M Kang; Sergio Uzzau; Rossano Atzeni; Maria Valentini; Davide Firinu; Lidia Leoni; Gianluca Rotta; Silvia Naitza; Andrea Angius; Mauro Congia; Michael B Whalen; Chris M Jones; David Schlessinger; Gonçalo R Abecasis; Edoardo Fiorillo; Serena Sanna; Francesco Cucca
Journal:  Cell       Date:  2013-09-26       Impact factor: 41.582

Review 3.  Control of alternative splicing in immune responses: many regulators, many predictions, much still to learn.

Authors:  Nicole M Martinez; Kristen W Lynch
Journal:  Immunol Rev       Date:  2013-05       Impact factor: 12.988

Review 4.  The three as: Alternative splicing, alternative polyadenylation and their impact on apoptosis in immune function.

Authors:  Davia Blake; Kristen W Lynch
Journal:  Immunol Rev       Date:  2021-08-08       Impact factor: 12.988

5.  Differential requirement for the CD45 splicing regulator hnRNPLL for accumulation of NKT and conventional T cells.

Authors:  Mehmet Yabas; Dale I Godfrey; Christopher C Goodnow; Gerard F Hoyne
Journal:  PLoS One       Date:  2011-11-04       Impact factor: 3.240

Review 6.  Uncovering the Role of RNA-Binding Proteins in Gene Expression in the Immune System.

Authors:  Manuel D Díaz-Muñoz; Martin Turner
Journal:  Front Immunol       Date:  2018-05-23       Impact factor: 7.561

7.  Genome-wide mouse mutagenesis reveals CD45-mediated T cell function as critical in protective immunity to HSV-1.

Authors:  Grégory Caignard; Gabriel A Leiva-Torres; Michael Leney-Greene; Benoit Charbonneau; Anne Dumaine; Nassima Fodil-Cornu; Michal Pyzik; Pablo Cingolani; Jeremy Schwartzentruber; Jeremy Dupaul-Chicoine; Huaijian Guo; Maya Saleh; André Veillette; Marc Lathrop; Mathieu Blanchette; Jacek Majewski; Angela Pearson; Silvia M Vidal
Journal:  PLoS Pathog       Date:  2013-09-12       Impact factor: 6.823

Review 8.  Dissecting mammalian immunity through mutation.

Authors:  Owen M Siggs
Journal:  Immunol Cell Biol       Date:  2014-02-11       Impact factor: 5.126

9.  The RNA-binding protein hnRNPLL induces a T cell alternative splicing program delineated by differential intron retention in polyadenylated RNA.

Authors:  Vicky Cho; Yan Mei; Arleen Sanny; Stephanie Chan; Anselm Enders; Edward M Bertram; Andy Tan; Christopher C Goodnow; T Daniel Andrews
Journal:  Genome Biol       Date:  2014-01-29       Impact factor: 13.583

Review 10.  The Role of Alternative Splicing in the Control of Immune Homeostasis and Cellular Differentiation.

Authors:  Mehmet Yabas; Hannah Elliott; Gerard F Hoyne
Journal:  Int J Mol Sci       Date:  2015-12-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.